PDF herunterladen
Thromb Haemost 1961; 6(02): 287-307
DOI: 10.1055/s-0038-1654562
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

The Use of DEAE Cellulose in the Preparation of a Factor VIII (AHG)-free Bovine Fibrinogen Reagent[*]

W. F Stapp   **
1   Central Coagulation Laboratory (Prof. Dr. E. Deutsch), The First Medical University Clinic (Prof. Dr. E. Lauda), University of Vienna Medical School, Vienna, Austria
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
12. Juli 2018 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Summary

Adequate fibrinogen reactivity is suggested as an additional requirement for specific fibrinogen reagents, to be added to the well known requirements of protein concentration, optimum pH, and optimum ionic strength. Reasons and a method for testing are outlined.

A method for the preparation of a specific fibrinogen reagent, deficient in factor VIII, from BaSO4 adsorbed bovine plasma is described in detail. The method described utilizes either fresh or regenerated DEAE cellulose as an adsorbent in a non-column chromatographic adsorption procedure, associated with a dialysis procedure in which the final fibrinogen product is concentrated and precipitated as a “euglobulin”. The “euglobulin” fibrinogen precipitate was then dissolved/suspended in buffered saline at a specific pH and NaCl concentration. Essentially the method can be briefly outlined into 5 separate steps:

1. Dialysis of BaSO4 adsorbed bovine plasma against 0.5% NaCl at pH 6.6 in 0.005 M Imidazole-HCl buffer.

2. Washing of DEAE cellulose with the same type of buffered NaCl solution to specific conditions.

3. Mixing of the dialyzed BaSO4 adsorbed bovine plasma with the washed DEAE cellulose and separation by centrifugation.

4. Concentration of the cellulose adsorbed plasma as a “euglobulin” fibrinogen precipitate by dialysis against running tap water.

5. Dissolving of the “euglobulin” fibrinogen precipitate in 0.9% NaCl buffered at pH 6.8.

Fibrinogen preparations, prepared with the use of regenerated DEAE cellulose were found to be similar to those prepared by fresh DEAE cellulose in fibrinogen reactivity and deficiency in factor VIII activity, but were found to have less fibrinogen concentration than those prepared using fresh DEAE cellulose.

Suggestions were also made for possibly increasing the over-all yield of the fibrinogen reagent through use of a “washing-elution” procedure.

The procedure that was used for regenerating the DEAE cellulose was also described in detail and commented upon.

* This investigation was supported in part from funds from a grant to Prof. Dr. E. Deutsch from the Blood Research Foundation, U.S.A.


** Home address: 1912 East Beach Street, Gulfport, Mississippi, U.S.A.


 

  • References

  • (1) Alexander B, De Vries A. Human Prothrombin: Quantitative studies on the labile factor and the restorative effects of normal hypofibrinogenemie and hemophilic plasma on the prothrombin time of stored plasma. J. clin. Invest. 28: 24 1949;
    CrossrefPubMedGoogle Scholar
  • (2) Astrup T. Biochemistry of Blood Coagulation. Thesis Acta physiol, scand.. 7 (Suppl. 21) 47 1944;
    PubMedGoogle Scholar
  • (3) Astrup T, Darling S. Investigations on Fibrinogen. Acta physiol. scand. 4: 45 1942;
    CrossrefPubMedGoogle Scholar
  • (4) Bounameaux Y. Dosage du facteur VIII en un temps. Acta haemat. (Basel) 17: 355 1957;
    CrossrefPubMedGoogle Scholar
  • (5) Banfi R. G, Tanturi C. A, Bay R. Prothrombin in preserved blood. J. Lab. clin. Med. 30: 512 1945;
    PubMedGoogle Scholar
  • (6) Bidwell E. The purification of bovine antihaemophilic globulin. Brit. J. Haemat. 1: 35 1955;
    CrossrefPubMedGoogle Scholar
  • (7) Biggs R, Macfarlane R. G. Human Blood Coagulation and its Disorders. 342 Blackwell Scientific Publications; Oxford: 1953
    Google Scholar
  • (8) Blombäck B, Blombäck M. Purification of human and bovine fibrinogen. Ark. Kemi. 10: 415 1956;
    PubMedGoogle Scholar
  • (9) Blombäck M. Purification of antihemophilic globulin. I. Some studies on stability of the antihemophilic globulin activity in Fraction I—0 and a method for its partial separation from fibrinogen. Ark. Kemi. 12: 387 1958;
    PubMedGoogle Scholar
  • (10) Cohn E. J, Strong L. E, Huges Jr W. L, Mulford D. J, Ashworth J. N, Melin M, Taylor H. L. Preparation of serum and plasma proteins IV. A system for the separation into fractions of protein and lipoprotein components of biological tissues and fluids. J. Amer. chem. Soc. 68: 459 1946;
    CrossrefPubMedGoogle Scholar
  • (11) van Creveld S, Hoorweg P. G, den Ottolander G. J. H, Veder H. A. Isolation of the antihemophilic factor from human plasma. Acta haemat. (Basel) 15: 1 1956;
    CrossrefPubMedGoogle Scholar
  • (12) van Creveld S, Veder H. A, Pascha C. N. The separation of AHF from Fibrinogen. II. Thromb. Diath. haem. 4: 211 1960;
    PubMedGoogle Scholar
  • (13) van Creveld S, Veder H. A, Pascha C. N, Kroeze W. G. The separation of AHF from Fibrinogen. Thromb. Diath. haem. 3: 572 1959;
    PubMedGoogle Scholar
  • (14) Didisheim P. An artificial reagent for the diagnosis of classical hemophilia. Science 129: 389 1959;
    CrossrefPubMedGoogle Scholar
  • (15) Fahey J. L, McCoy P. G, Goulian M. Chromatography of serum proteins in normal and pathological sera; the distribution of protein bound carbohydrate and cholesterol, Siderophilin, thyroxin binding protein, B12 binding protein, alkaline and acid phosphatases, radio iodinated albumin and myeloproteins. J. clin. Invest. 37: 272 1958;
    CrossrefPubMedGoogle Scholar
  • (16) Frédéricq L. „De l’existence dans le plasma sanguine d’une substance albummoide se coagulant a + 56° C.” Gand 1877. Extrait des Annales de la Société de Médecine de Gand.
    PubMedGoogle Scholar
  • (17) Graham J. B, Penick G. D, Brinkhous K. M. Utilization of Antihemophilic factor during clotting of canine blood and plasma. Amer. J. Physiol. 165: 710 1951;
    PubMedGoogle Scholar
  • (18) Hammersten O. Untersuchungen über die sog. Fibringeneratoren, den Faserstoff und die Gerinnung des Fibrinogens. Kap. I. Eiweißkörper und verwandte Stoffe. Malys Jahresber. d. Tierchemie 8: 15 1876;
    PubMedGoogle Scholar
  • (19) Jaques L. B. The reducing properties of fibrinogen. Biochem. J. 37: 344 1943;
    CrossrefPubMedGoogle Scholar
  • (20) Jung E. G. A rapid quantitative assay of Factor VIII (AHG) without the use of hemophilia A plasma. Thromb. Diath. haem. 4: 323 1960;
    PubMedGoogle Scholar
  • (21) Kaplan S, Friedman I. A. Effects of ultraviolet ray irradiation on clotting mechanism of plasma. J. Amer. med. Ass. 147: 229 1951;
    CrossrefPubMedGoogle Scholar
  • (22) Keckwick R. A, Mackay M. E, Record B. R. Fractionation of human plasma with ether. Nature 157: 629 1946;
    PubMedGoogle Scholar
  • (23) Lorand L, Laki K. A simple method for purifying an activator of prothrombin. Biochim. biophys. Acta 13: 448 1954;
    CrossrefPubMedGoogle Scholar
  • (24) Lozner E. L, Kark R, Taylor F. H. L. The coagulation defect in hemophilia. The clot promoting activity in hemophilia of Berkefelded normal human plasma free from fibrinogen and prothrombin. J. clin. Invest. 18: 603 1939;
    CrossrefPubMedGoogle Scholar
  • (25) Mertz E. T, Owen C. A. Imidazole buffer: Its use in blood clotting studies. Proc. Soc. exp. Biol. (N. Y.) 43: 204 1940;
    CrossrefPubMedGoogle Scholar
  • (26) Owren P. A. The coagulation of blood. Investigations on a new clotting factor. Thesis. Acta med. scand. 128 (Suppl. 194) 125 1947;
    PubMedGoogle Scholar
  • (27) Peterson E. A, Sober H. A. Chromatography of Proteins I. Cellulose Ion Exchange Adsorbents. J. Amer. chem. Soc. 78: 751 1956;
    CrossrefPubMedGoogle Scholar
  • (28) Pool J. G, Robinson J. Observations on plasma banking and transfusion procedures for haemophilia patients using a quantitative assay for AHG. Brit. J. Haemat. 5: 24 1959;
    CrossrefPubMedGoogle Scholar
  • (29) Porath J. Some cellulose ion exchangers of low substitution and their chromatographic application. Ark. Kemi. 11: 97 1956;
    PubMedGoogle Scholar
  • (30) Quick A. J. Hemorrhagic Diseases. a) 415 b) p. 34—35, c) p. 432. Lea and Febiger; Philadelphia: 1957
    Google Scholar
  • (31) Ratnoff O. D. An accelerating property of plasma for the coagulation of fibrinogen by thrombin. J. clin. Invest. 33: 1175 1954;
    CrossrefPubMedGoogle Scholar
  • (32) Rosenfeld L, Shinowara G. Y. Enzyme studies on human blood. The fibrinogen content of stored plasma. J. Lab. clin. Med. 37: 311 1951;
    PubMedGoogle Scholar
  • (33) Seegers W. H, Landaburu R, Fenichel R. L. Isolation of platelet cofactor I from plasma and some of the properties of the preparation. Amer. J. Physiol. 190: 1 1957;
    PubMedGoogle Scholar
  • (34) Schulz F. H. Eine einfache volumetrische Fibrinbestimmung. Ärztl. Lab. 1: 107 1955;
    PubMedGoogle Scholar
  • (35) Shinowara G. Enzyme studies on human blood. XL The isolation and characterization of thromboplastic cell and plasma components. J. Lab. clin. Med. 38: 11 1951;
    PubMedGoogle Scholar
  • (36) Soulier J. P. A new adsorption agent for coagulation factors. J. clin. Path. 12: 303 1959;
    CrossrefPubMedGoogle Scholar
  • (37) Soulier J. P, Gobbiet T, Larrieu J. J. Séparation du fiibrinogène et du facteur antihémophilique A. Rev. Hémat. 12: 481 1957;
    PubMedGoogle Scholar
  • (38) Stefanini M. Antithrombin activity of stored plasma. Amer. J. clin. Path. 18: 537 1948;
    PubMedGoogle Scholar
  • (39) Stormorken H. Reactivity of stored plasma to thrombin, with reference to the fibrinogen conversion accelerator and heparinoid activity. Brit. J. Haemat. 3: 299 1957;
    CrossrefPubMedGoogle Scholar
  • (40) Surgenor D. M, Steele B. B. Studies on the nature of the antihemophilic activity of normal human plasma. Sixth Annual Symposium on Blood. Thromb. Diath. haem. 1: 563 1957;
    PubMedGoogle Scholar
  • (41) Triantaphyllopoulas D. C, Quick A. J, Greenwall T. J. Action of disodium ethylenediamine tetracetate on blood coagulation. Evidence of the development of heparinoid activity during incubation or aeration of plasma. Blood 10: 534 1955;
    PubMedGoogle Scholar
  • (42) Wagner R. H, Richardson B. A, Brinkhous K. M. A study of the separation of fibrinogen and antihemophilic factor (AHF) in canine, porcine, and human plasmas. Thromb. Diath. haem. 1: 1 1957;
    PubMedGoogle Scholar
  • (43) Ware A. G, Guest M. M, Seegers W. H. Fibrinogen: with special reference to its preparation and certain properties of the product. Arch. Biochem. 13: 231 1947;
    PubMedGoogle Scholar
  • (44) Warner E. D, Brinkhous K, Smith H. P. The titration of prothrombin in certain plasmas. Arch. Path. (Chicago) 18: 587 1934;
    PubMedGoogle Scholar
  • (45) Williams T. L. An Introduction to Chromatography. 21 1947—1948 Reprint Edition Blackie and Son Limited; London and Glasgow.:
    Google Scholar